The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition
10.1182/blood-2007-06-097774
Saved in:
Main Authors: | Chng, W.J., Braggio, E., Fonseca, R., Mulligan, G., Bryant, B., Remstein, E., Dogan, A., Valdez, R. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26703 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Centrosomes and myeloma; aneuploidy and proliferation
by: Chng, W.J., et al.
Published: (2016) -
A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma
by: Chung, T.-H., et al.
Published: (2014) -
Unraveling the role of aurora A beyond centrosomes and spindle assembly: implications in muscle differentiation
by: Dhanasekaran, Karthigeyan, et al.
Published: (2019) -
Isolation and characterization of Aurora-A Kinase Interacting Protein (AKIP), A novel negative regulator for Aurora-A Kinase
by: LIM SHEN KIAT
Published: (2010) -
Natural history and prognostic factors at first relapse in multiple myeloma
by: Wang, C., et al.
Published: (2021)